Virtu KCG Holdings’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-4,688
Closed -$56K 3499
2017
Q1
$56K Buy
4,688
+851
+22% +$18.6K ﹤0.01% 2818
2016
Q4
$82K Buy
3,837
+2,634
+219% +$101K ﹤0.01% 2978
2016
Q3
$92K Sell
1,203
-1,715
-59% -$125K ﹤0.01% 2657
2016
Q2
$220K Buy
2,918
+1,798
+161% +$145K ﹤0.01% 2227
2016
Q1
$98K Buy
+1,120
New +$98K ﹤0.01% 2337

Other funds holding TNDM

Virtu KCG Holdings's TNDM Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Tandem Diabetes Care (TNDM) in Q2 2017, closing a stake of 4,688 shares — an estimated $56K sold.

Virtu KCG Holdings first reported a position in TNDM in Q1 2016 and held it in 5 quarters. The position peaked at $220K in Q2 2016. 63 funds tracked by Wall St. Rank hold TNDM as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Tandem Diabetes Care position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 4,688 Tandem Diabetes Care shares in Q2 2017, an estimated $56K.
  • Virtu KCG Holdings first reported a position in Tandem Diabetes Care in Q1 2016 and held it in 5 quarters.
  • Virtu KCG Holdings's Tandem Diabetes Care position peaked at $220K in Q2 2016.
  • 63 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.